Business
Healthcare IT player announces first profitable quarter: Ubika Research issues report on Medworxx Solutions
Healthcare IT player announces first profitable quarter: Ubika Research issues report on Medworxx...
About this update from Regenx Tech Corp
[{"type":"text","content":"\nHealthcare IT player announces first profitable quarter: Ubika Research issues report on Medworxx Solutions\n\n\n Nov. 23, 2010 (Baystreet.ca) -- TORONTO, Canada - Ubika Research has issued a research bulletin on the Q3 2010 results announced by Medworxx Solutions Inc (TSX VENTURE: MWX) (CVE: MWX) on Nov 18, 2010. The research bulletin is titled \" 3rd Quarter Results: First profitable quarter for this fast growing health care IT player”. To view this research bulletin and access all research reports on Medworxx please visit: http://www.smallcappower.com/microsite/medworxx_solutions_inc_research_reports.html Medworxx is the leader in the growing field of patient flow products within the fast growing health care IT sector. Patient flow has emerged as a key area of focus in hospitals as countries grapple with spiraling healthcare costs, lack of enough hospital beds and the pressures of an ageing population with complex needs. Medworxx has over 120 hospitals as its customers. Ubika Research believes that there are very few small cap publicly traded health care IT companies in Canada with real revenues and a solid blue chip customer base in health care vertical. Other than Medworxx, QHR Technologies (TSXV: QHR) (CVE: QHR) and ZoomMed Inc (TSXV: ZMD) (CVE: ZMD) are among the few other publicly listed small cap health care IT companies in Canada that we are aware, for investors to get exposure to healthcare IT in the small cap space. To view our CEO video interview with Medworxx President & CEO, Mr. Dan Matlow, please visit: http://www.smallcappower.com/microsite/medworxx_solutions_inc_videos.html About Ubika ResearchUbika Research is an investment research and capital market services firm based in Toronto and Vancouver. It provides comprehensive research, communication and capital market exposure program to highlight the investment potential in micro and small cap companies. For more information visit: ubikaresearch.com DisclosureExcept for the historical information presented herein, matters discussed in this document contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements.Ubika Research, a division of Ubika Corporation, is not registered with any fi...